BridgeMD
New treatment option for Lung Cancer
Official title Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
ClinicalTrials.gov ID: NCT07026110
What this study is testing
What is [68Ga]Ga-NOTA-T4?
[68Ga]Ga-NOTA-T4 is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for lung cancer.
Also referred to as [68Ga]T4.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study aims to explore the efficacy of Trop2, EpCAM-specific PET/CT imaging for noninvasive visualization of Trop2 or EpCAM expression levels in non-small cell lung cancer; and to explore the differences between novel target-specific PET/CT examinations and conventional 18F-FDG PET/CT in the diagnosis and differential diagnosis of solid lung nodules.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Age 18-80 years;
- Imaging studies suspecting non-small cell lung cancer;
- Solid lung nodules (≥8 mm in diameter) diagnosed by chest ct, which are subject to 18F-FDG PET/CT and surgical resection/biopsy of lung nodules...
- Patients or family members agreed to participate in this clinical study and signed an informed consent form.
You likely can't join if
- Women during pregnancy and lactation;
- Persons with a history of surgery and trauma that significantly affects metabolic distribution and anatomical structure;
- Persons with severe other systemic diseases or known hypersensitivity to humanized monoclonal antibody products;
- Patient is unable to cooperate in completing the PET/CT examination;
- Patient has participated in other clinical studies within the past year that have resulted in radiation exposures in excess of an effective dose of...
- Patient should not participate in this clinical trial in the opinion of the investigator.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.